Enliven Therapeutics (NASDAQ:ELVN – Free Report) had its target price upped by Mizuho from $62.00 to $73.00 in a research report report published on Tuesday,Benzinga reports. They currently have an outperform rating on the stock. A number of other brokerages have also issued reports on ELVN. Weiss Ratings reiterated a “sell (d-)” rating on shares […]

Intensity Therapeutics (NASDAQ:INTS – Free Report) had its price objective lifted by HC Wainwright from $5.00 to $7.00 in a report published on Tuesday, Marketbeat Ratings reports. HC Wainwright currently has a buy rating on the stock. HC Wainwright also issued estimates for Intensity Therapeutics’ Q3 2026 earnings at ($1.11) EPS, Q4 2026 earnings at […]

Iovance Biotherapeutics (NASDAQ:IOVA – Get Free Report) had its price objective boosted by equities researchers at Mizuho from $10.00 to $11.00 in a report issued on Tuesday,Benzinga reports. The brokerage presently has an “outperform” rating on the biotechnology company’s stock. Mizuho’s price target indicates a potential upside of 54.93% from the stock’s current price. A […]